S'abonner

Influenza-derived peptides cross-react with allergens and provide asthma protection - 06/09/18

Doi : 10.1016/j.jaci.2017.07.056 
Chrysanthi Skevaki, MD, PhD a, , Christoph Hudemann, PhD a, , Mikhail Matrosovich, PhD b, Christian Möbs, PhD c, Sinu Paul, PhD d, Andreas Wachtendorf a, Bilal Alashkar Alhamwe, BSc a, Daniel P. Potaczek, MD, PhD a, e, Stefanie Hagner, PhD a, Diethard Gemsa, MD a, Holger Garn, PhD a, Alessandro Sette, PhD d, Harald Renz, MD a,
a Institute of Laboratory Medicine and Pathobiochemistry, Member of the German Center for Lung Research (DZL), Philipps University Marburg, Marburg, Germany 
b Institute of Virology, Philipps University Marburg, Marburg, Germany 
c Department of Dermatology and Allergology, Philipps University Marburg, Marburg, Germany 
d La Jolla Institute for Allergy and Immunology, La Jolla, Calif 
e John Paul II Hospital, Krakow, Poland 

Corresponding author: Harald Renz, MD, Institute of Laboratory Medicine, Philipps University Marburg, Baldingerstrasse, 35043 Marburg, Germany.Institute of Laboratory MedicinePhilipps University MarburgBaldingerstrasseMarburg35043Germany

Abstract

Background

The hygiene hypothesis is the leading concept to explain the current asthma epidemic, which is built on the observation that a lack of bacterial contact early in life induces allergic TH2 immune responses.

Objective

Because little is known about the contribution of respiratory tract viruses in this context, we evaluated the effect of prior influenza infection on the development of allergic asthma.

Methods

Mice were infected with influenza and, once recovered, subjected to an ovalbumin- or house dust mite–induced experimental asthma protocol. Influenza-polarized effector memory T (Tem) cells were transferred adoptively to allergen-sensitized animals before allergen challenge. A comprehensive in silico analysis assessed homologies between virus- and allergen-derived proteins. Influenza-polarized Tem cells were stimulated ex vivo with candidate peptides. Mice were immunized with a pool of virus-derived T-cell epitopes.

Results

In 2 murine models we found a long-lasting preventive effect against experimental asthma features. Protection could be attributed about equally to CD4+ and CD8+ Tem cells from influenza-infected mice. An in silico bioinformatic analysis identified 4 influenza- and 3 allergen-derived MHC class I and MHC class II candidate T-cell epitopes with potential antigen-specific cross-reactivity between influenza and allergens. Lymphocytes from influenza-infected mice produced IFN-γ and IL-2 but not IL-5 on stimulation with the aforementioned peptides. Immunization with a mixture of the influenza peptides conferred asthma protection, and peptide-immunized mice transferred protection through CD4+ and CD8+ Tem cells.

Conclusion

For the first time, our results illustrate heterologous immunity of virus-infected animals toward allergens. This finding extends the original hygiene hypothesis.

Le texte complet de cet article est disponible en PDF.

Graphical abstract




Le texte complet de cet article est disponible en PDF.

Key words : Influenza virus, asthma, hygiene hypothesis, effector memory cells, heterologous immunity

Abbreviations used : BAL, BLAST, CD62L, dpi, HBV, HDM, H1N1, IEDB, IFV, NP, OVA, PA, PAS, PB, PBST, TCR, Tem


Plan


 Supported by the Deutsche Forschungsgemeinschaft (DFG)–funded SFB 1021, the German Center for Lung Research (DZL; 82DZL00502/A2), and the German Academic Exchange Service (DAAD; B.A.A., personal reference number: 91559386).
 Disclosure of potential conflict of interest: C. Skevaki has received grants from the German Research Foundation (DFG), the German Center for Lung Research (DZL), and the European Union FP7 PREDICTA, and has received payment for research projects from Hycor and Mead Johnson Nutritional and has received consultation fees from Hycor and Bencard. M. Matrosovich has received a grant from the German Research Foundation. H. Renz has received a grant from the German Research Foundation and payment for lectures from Allergopharma, Novartis, Thermo Fisher, Danone, Mead Johnson Nutritional, and Bencard and has received payment for research and development projects from Hycor, Mead Johnson, and Beckman Coulter. The rest of the authors declare that they have no relevant conflicts of interest.


© 2017  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 142 - N° 3

P. 804-814 - septembre 2018 Retour au numéro
Article précédent Article précédent
  • Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin–driven IL-9+ and IL-13+ type 2 innate lymphoid cell subpopulations
  • Mukesh Verma, Sucai Liu, Lidia Michalec, Anand Sripada, Magdalena M. Gorska, Rafeul Alam
| Article suivant Article suivant
  • Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease
  • Patrick Mallia, Jessica Webber, Simren K. Gill, Maria-Belen Trujillo-Torralbo, Maria Adelaide Calderazzo, Lydia Finney, Eteri Bakhsoliani, Hugo Farne, Aran Singanayagam, Joseph Footitt, Richard Hewitt, Tatiana Kebadze, Julia Aniscenko, Vijay Padmanaban, Philip L. Molyneaux, Ian M. Adcock, Peter J. Barnes, Kazihuro Ito, Sarah L. Elkin, Onn Min Kon, William O. Cookson, Miriam F. Moffat, Sebastian L. Johnston, John S. Tregoning

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.